Stockscreener 앱 받기
11.41
6.24%
-0.76
시간 외 거래:
11.41
전일 마감가:
$12.17
열려 있는:
$12.02
하루 거래량:
432.41K
Relative Volume:
8.75
시가총액:
$264.90M
수익:
$59,000
순이익/손실:
$-21.81M
주가수익비율:
-0.6735
EPS:
-16.9418
순현금흐름:
$-18.07M
1주 성능:
-3.06%
1개월 성능:
+7.04%
6개월 성능:
+81.11%
1년 성능:
+277.81%
1일 변동 폭
$11.41
$12.40
1주일 범위
$11.41
$13.29
52주 변동 폭
$2.69
$13.29
Benitec Biopharma Inc Stock (BNTC) Company Profile
명칭
Benitec Biopharma Inc
전화
(510) 780-0819
주소
3940 TRUST WAY, HAYWARD, CA
BNTC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BNTC
Benitec Biopharma Inc
|
11.41 | 264.90M | 59,000 | -21.81M | -18.07M | -10.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Benitec Biopharma Inc Stock (BNTC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-16 | 개시 | H.C. Wainwright | Buy |
| 2024-12-13 | 개시 | Robert W. Baird | Outperform |
| 2024-10-16 | 개시 | Oppenheimer | Outperform |
| 2024-09-12 | 개시 | Guggenheim | Buy |
| 2024-07-22 | 개시 | Leerink Partners | Outperform |
| 2024-06-13 | 개시 | Piper Sandler | Overweight |
| 2020-10-05 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2020-04-20 | 개시 | Ladenburg Thalmann | Buy |
| 2016-02-26 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2015-12-31 | 재확인 | Maxim Group | Buy |
| 2015-09-16 | 재확인 | Maxim Group | Buy |
모두보기
Benitec Biopharma Inc 주식(BNTC)의 최신 뉴스
Equities Analysts Issue Forecasts for BNTC Q2 Earnings - Defense World
Q2 Earnings Estimate for BNTC Issued By HC Wainwright - MarketBeat
Where are the Opportunities in (BNTC) - Stock Traders Daily
Hedge funds investors own a significant stake of 38% in Benitec Biopharma Inc. (NASDAQ:BNTC) - Yahoo Finance
Benitec Biopharma stock soars to 52-week high of $13.29 - Investing.com
Benitec Biopharma (NASDAQ:BNTC) Now Covered by HC Wainwright - Defense World
Benitec Biopharma initiated with a Buy at H.C. Wainwright - Yahoo Finance
Benitec Biopharma's SWOT analysis: gene therapy stock shows promise in OPMD - Investing.com
Benitec Biopharma announces executive team changes - Investing.com
Benitec Biopharma (NASDAQ:BNTC) Earns Buy Rating from Analysts at HC Wainwright - MarketBeat
Benitec Biopharma (NASDAQ:BNTC) Coverage Initiated by Analysts at HC Wainwright - MarketBeat
Benitec Biopharma (NASDAQ:BNTC) Appoints New Chief Operating Officer and Makes Changes to Executive Officers’ Roles and Compensation - Defense World
Benitec Biopharma announces executive team changes By Investing.com - Investing.com UK
Short Interest in Benitec Biopharma Inc. (NASDAQ:BNTC) Grows By 6.9% - MarketBeat
Robert W. Baird Begins Coverage on Benitec Biopharma (NASDAQ:BNTC) - Defense World
Benitec Biopharma Shakes Up Management Team - MarketWatch
Baird Initiates Coverage of Benitec Biopharma (BNTC) with Outperform Recommendation - MSN
Benitec Biopharma (NASDAQ:BNTC) Coverage Initiated at Robert W. Baird - MarketBeat
Baird sets $30 target on Benitec BioPharma, cites gene therapy By Investing.com - Investing.com UK
Benitec Biopharma (BNTC) Is a Great Choice for 'Trend' Investors, Here's Why - MSN
Benitec Biopharma approves preferred stock issuance By Investing.com - Investing.com Canada
Benitec Biopharma approves preferred stock issuance - Investing.com
Benitec Biopharma stock soars to 52-week high of $12.95 By Investing.com - Investing.com Canada
Wall Street Analysts See an 113.71% Upside in Benitec Biopharma (BNTC): Can the Stock Really Move This High? - Yahoo Finance
When (BNTC) Moves Investors should Listen - Stock Traders Daily
Benitec Biopharma shareholders approve key proposals By Investing.com - Investing.com Canada
JANUS HENDERSON GROUP PLC Increases Stake in Benitec Biopharma I - GuruFocus.com
Brokerages Set Benitec Biopharma Inc. (NASDAQ:BNTC) PT at $22.60 - MarketBeat
Benitec Biopharma Inc. (NASDAQ:BNTC) Given Consensus Rating of “Buy” by Analysts - Defense World
Guggenheim Reaffirms “Buy” Rating for Benitec Biopharma (NASDAQ:BNTC) - Defense World
Benitec Biopharma's SWOT analysis: promising OPMD treatment lifts stock outlook - Investing.com India
Suvretta Capital Management LLC Has $81.14 Million Stake in Benitec Biopharma Inc. (NASDAQ:BNTC) - MarketBeat
Benitec Biopharma to Participate in Upcoming Investor Conferences in December - GlobeNewswire
Benitec Biopharma to Present at Major Healthcare Conferences in December | BNTC Stock News - StockTitan
Suvretta Capital Management's Strategic Acquisition in Benitec B - GuruFocus.com
How To Trade (BNTC) - Stock Traders Daily
Simplify Asset Management Inc. Increases Position in Benitec Biopharma Inc. (NASDAQ:BNTC) - MarketBeat
Benitec Biopharma Inc reports results for the quarter ended September 30Earnings Summary - XM
Benitec Biopharma Inc. (BNTC) Quarterly 10-Q Report - Quartzy
Analysis of JANUS HENDERSON GROUP PLC's Recent Transaction in Be - GuruFocus.com
Benitec Biopharma executives receive performance bonuses - Investing.com
Benitec Biopharma Awards Bonuses to Key Executives - TipRanks
Benitec Biopharma Releases First Quarter 2025 Financial Results and Provides Operational Update - The Manila Times
Benitec's BB-301 Shows Major Clinical Gains: 35-40% OPMD Symptom Improvement | BNTC Stock News - StockTitan
Benitec Biopharma Inc. (NASDAQ:BNTC) Short Interest Update - MarketBeat
Benitec Biopharma Inc. (NASDAQ:BNTC) Receives $22.60 Average Target Price from Analysts - MarketBeat
Benitec Biopharma Inc. (NASDAQ:BNTC) Receives Average Recommendation of “Buy” from Analysts - Defense World
(BNTC) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Benitec Biopharma CEO to Participate in the Guggenheim Securities Healthcare Conference - GlobeNewswire
Long Term Trading Analysis for (BNTC) - Stock Traders Daily
Piper Sandler Initiates Coverage of Benitec Biopharma (BNTC) with Overweight Recommendation - MSN
Benitec Biopharma Inc (BNTC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Benitec Biopharma Inc 주식 (BNTC) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Nov 20 '24 |
Buy |
10.22 |
27,436 |
280,396 |
7,920,175 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Nov 19 '24 |
Buy |
9.73 |
14,000 |
136,220 |
7,895,815 |
2.88%
2.65%
자본화:
|
볼륨(24시간):